AVIR Next Earnings Date Notes

— Atea Pharmaceuticals (NASDAQ: AVIR) is a clinical-stage biopharmaceutical company focused on discovering, developing, & commercializing oral antiviral therapeutics to address significant unmet medical needs. Its lead product candidate, bemnifosbuvir, is being developed for the treatment of COVID-19 as well as hepatitis C, with the goal of providing innovative & convenient treatment options for viral infections. Investors following Atea should pay close attention to key business metrics such as clinical trial progress & results, regulatory milestones (especially for bemnifosbuvir), cash burn & available cash on hand, research & development (R&D) expenses, & detailed pipeline updates. Milestones involving partnership announcements, licensing deals, or government collaboration can also significantly impact the company’s prospects. Since Atea is pre-revenue and highly dependent on successful clinical outcomes, the timing & outcome of clinical trials are especially critical. As you listen to the next earnings call, look for management’s commentary on the status of late-stage trials, upcoming data readouts, anticipated regulatory interactions, and updated guidance on operating expenses & cash runway, as these are central to assessing Atea’s long-term potential. The next projected earnings date for AVIR is 5/11/2026 after close (stay tuned for a confirmed earnings date once announced).

AVIR Next Earnings Date FAQ

On this page we presented the AVIR Next Earnings Date information for Atea Pharmaceuticals along with recent past earnings dates. For Q4 of 2025, AVIR reported earnings of -0.570/share, with the earnings report taking place on 3/5/2026. For Q3 of 2025, AVIR reported earnings of -0.530/share, with the earnings report taking place on 11/12/2025. For Q2 of 2025, AVIR reported earnings of -0.440/share, with the earnings report taking place on 8/7/2025. For Q1 of 2025, AVIR reported earnings of -0.400/share, with the earnings report taking place on 5/12/2025. For Q4 of 2024, AVIR reported earnings of -0.400/share, with the earnings report taking place on 3/6/2025. Based on these past earnings dates, the projected next earnings date for AVIR is 5/11/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Atea Pharmaceuticals. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Atea Pharmaceuticals shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Atea Pharmaceuticals next earnings dates as well as any other stock out there in our coverage universe, to see when the next AVIR earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up AVIR's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the AVIR next earnings date.